Products for Research Use Only
RegisterLogin

TRK-IN-30

CAT: 0804-HY-168858Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-168858Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TRK-IN-30 (Compound C11) is the inhibitor for tropomyosin receptor kinase (TRK) that inhibits TRKA, TRKB and TRKC and drug resistant mutant TRKAG595R with an IC50 of 1.8, 0.98, 3.8, and 54 nM, respectively. TRK-IN-30 inhibits the activation of the downstream PI3K/AKT and MEK/ERK signaling pathways. TRK-IN-30 inhibits the colony formation and cell migration of Km-12, arrests the cell cycle at G0/G1 phase, and induces apoptosis in Km-12[1].
UNSPSC
12352211
Target
Trk Receptor
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
NC1=C(C(NC2=CC(OC)=C(OC)C=C2)=O)C=CC=C1NC3=CC(NC=C4C#N)=C4C=C3
Molecular Formula
C24H21N5O3
Molecular Weight
427.46
References & Citations
[1]Xu S, et al., Design, synthesis and biological evaluation of novel 1H-indole-3-carbonitrile derivatives as potent TRK Inhibitors. Eur J Med Chem. 2025 Jan 3;285:117231.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-144451TRK-IN-12
HY-160166TRK-IN-26
HY-146521TRK-IN-15
HY-12327Trk-IN-1
HY-144423Trk-IN-10
HY-146519TRK-IN-14
HY-160165TRK-IN-25
HY-161179TRK-IN-27
HY-161819TRK-IN-29
HY-146522TRK-IN-16

Alternative Products

CatalogName
GTR19249970-01TRK-IN-30
PA1321-STrk-A
338192-01Trk A
GTR18303659Trk Antibody
T212244-01TRK-IN-32
T211064-01TRK-IN-31
T210169-01TRK-IN-29
T209555-01TRK-IN-22
T87568-01TRK-IN-25
T63346-01TRK-IN-18

Popular Products